For: | Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon. World J Gastroenterol 2005; 11(18): 2773-2776 [PMID: 15884120 DOI: 10.3748/wjg.v11.i18.2773] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i18/2773.htm |
Number | Citing Articles |
1 |
Giovanni Latella, Carmelo Scarpignato. Rifaximin in the management of colonic diverticular disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6): 585 doi: 10.1586/egh.09.63
|
2 |
V. L. Martynov, A. Kh. Khairdinov. THE ETHIOPATOGENESIS AND THE ANALYSIS OF AN ANTIBIOTIC TREATMENT OF A SMALL INTESTINE BACTERIAL OVERGROWTH SYNDROME. Bulletin of Siberian Medicine 2015; 14(3): 49 doi: 10.20538/1682-0363-2015-3-49-62
|
3 |
R. D'INCÀ, F. POMERRI, M. G. VETTORATO, E. DAL PONT, V. DI LEO, A. FERRONATO, V. MEDICI, G. C. STURNIOLO. Interaction between rifaximin and dietary fibre in patients with diverticular disease. Alimentary Pharmacology & Therapeutics 2007; 25(7): 771 doi: 10.1111/j.1365-2036.2007.03266.x
|
4 |
L. Gatta, C. Scarpignato. Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Alimentary Pharmacology & Therapeutics 2017; 45(5): 604 doi: 10.1111/apt.13928
|
5 |
Hassan Al Harakeh, Abhilash J. Paily, Samer Doughan, Irshad Shaikh. Recurrent Acute Diverticulitis: When to Operate?. Inflammatory Intestinal Diseases 2018; 3(2): 91 doi: 10.1159/000494973
|
6 |
Sergio Peralta, Claudia Cottone, Tiziana Doveri, Piero Luigi Almasio, Antonio Craxi. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin. World Journal of Gastroenterology 2009; 15(21): 2628-2631 doi: 10.3748/wjg.15.2628
|
7 |
Chia-Chang Chen, Jiann-Sheng Su, Hong-Zen Yeh, Chi-Sen Chang, Yen-Chun Peng, Chih-Wei Tseng, Yu-Tso Chen, Cheng-Li Lin, Chia-Hung Kao. Association Between Colonic Diverticulosis and Erectile Dysfunction. Medicine 2015; 94(47): e2042 doi: 10.1097/MD.0000000000002042
|
8 |
Antonio Tursi. New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opinion on Pharmacotherapy 2007; 8(3): 299 doi: 10.1517/14656566.8.3.299
|
9 |
Thomas R. Ziegler, Conrad R. Cole. Small bowel bacterial overgrowth in adults: A potential contributor to intestinal failure. Current Gastroenterology Reports 2007; 9(6) doi: 10.1007/s11894-007-0060-x
|
10 |
Francesca Romana Ponziani, Viviana Gerardi, Antonio Gasbarrini. Diagnosis and treatment of small intestinal bacterial overgrowth. Expert Review of Gastroenterology & Hepatology 2016; 10(2): 215 doi: 10.1586/17474124.2016.1110017
|
11 |
Michel Bouchoucha, Marinos Fysekidis, Céline Lekhal, Bakhtiar Daniel Bejou, Jean-Marc Sabate, Robert Benamouzig. COLIGENTA treatment of small intestinal bacterial overgrowth. Results of an open study.. Digestive and Liver Disease 2021; 53(1): 66 doi: 10.1016/j.dld.2020.10.032
|
12 |
Julius Špičák, Miloš Kučera, Gabriela Suchánková. Diverticular disease: diagnosis and treatment. Vnitřní lékařství 2018; 64(6): 621 doi: 10.36290/vnl.2018.086
|
13 |
Carmelo Scarpignato, Anna Bertelé, Antonio Tursi. Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease. Journal of Clinical Gastroenterology 2016; 50(Supplement 1): S70 doi: 10.1097/MCG.0000000000000641
|
14 |
Sarah Khan, Lin Chang. Diagnosis and management of IBS. Nature Reviews Gastroenterology & Hepatology 2010; 7(10): 565 doi: 10.1038/nrgastro.2010.137
|
15 |
Danielle Harari. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. 2010; : 909 doi: 10.1016/B978-1-4160-6231-8.10108-4
|
16 |
Jessica Cottreau, Shannon F Baker, Herbert L DuPont, Kevin W Garey. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections. Expert Review of Anti-infective Therapy 2010; 8(7): 747 doi: 10.1586/eri.10.58
|
17 |
E.-M. Schmidt, R. Jakobs. Divertikulose und Divertikulitis im Alter. Der Gastroenterologe 2012; 7(4): 320 doi: 10.1007/s11377-012-0660-3
|
18 |
H. J. Heppner. Spezifische Aspekte bei Infektionserkrankungen im Alter. Der Gastroenterologe 2021; 16(5): 355 doi: 10.1007/s11377-021-00548-w
|
19 |
Erica Cohen, Garth Fuller, Roger Bolus, Rusha Modi, Michelle Vu, Kamyar Shahedi, Rena Shah, Mary Atia, Nicole Kurzbard, Victoria Sheen, Nikhil Agarwal, Marc Kaneshiro, Linnette Yen, Paul Hodgkins, M. Haim Erder, Brennan Spiegel. Increased Risk for Irritable Bowel Syndrome After Acute Diverticulitis. Clinical Gastroenterology and Hepatology 2013; 11(12): 1614 doi: 10.1016/j.cgh.2013.03.007
|
20 |
Carmelo Scarpignato, Neil Stollman. Colonic Diverticular Disease. 2022; : 209 doi: 10.1007/978-3-030-93761-4_18
|
21 |
Antonio Tursi. Colonic microflora imbalance and diverticular disease. Digestive and Liver Disease 2010; 42(6): 458 doi: 10.1016/j.dld.2009.09.003
|
22 |
Lisa L Strate, Rusha Modi, Erica Cohen, Brennan M R Spiegel. Diverticular Disease as a Chronic Illness: Evolving Epidemiologic and Clinical Insights. American Journal of Gastroenterology 2012; 107(10): 1486 doi: 10.1038/ajg.2012.194
|
23 |
Carmelo Scarpignato, Giovanni Barbara, Angel Lanas, Lisa L. Strate. Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017. Therapeutic Advances in Gastroenterology 2018; 11: 175628481877130 doi: 10.1177/1756284818771305
|
24 |
Alexandra M. Zaborowski, Des C. Winter. Evidence-based treatment strategies for acute diverticulitis. International Journal of Colorectal Disease 2021; 36(3): 467 doi: 10.1007/s00384-020-03788-4
|
25 |
Georgia Brown, Emily C. Hoedt, Simon Keely, Ayesha Shah, Marjorie M. Walker, Gerald Holtmann, Nicholas J. Talley. Role of the duodenal microbiota in functional dyspepsia. Neurogastroenterology & Motility 2022; 34(11) doi: 10.1111/nmo.14372
|
26 |
E. SCARPELLINI, M. GABRIELLI, C. E. LAURITANO, A. LUPASCU, G. MERRA, G. CAMMAROTA, I. A. CAZZATO, G. GASBARRINI, A. GASBARRINI. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Alimentary Pharmacology & Therapeutics 2007; 25(7): 781 doi: 10.1111/j.1365-2036.2007.03259.x
|
27 |
Paul J. Lappinga, Susan C. Abraham, Joseph A. Murray, Emily A. Vetter, Robin Patel, Tsung-Teh Wu. Small Intestinal Bacterial Overgrowth: Histopathologic Features and Clinical Correlates in an Underrecognized Entity. Archives of Pathology & Laboratory Medicine 2010; 134(2): 264 doi: 10.5858/134.2.264
|
28 |
Yu. A. Shelygin, V. T. Ivashkin, S. I. Achkasov, A. I. Moskalev, V. M. Тimerbulatov, A. V. Sazhin, S. G. Shapovalyants, O. Y. Karpukhin, N. V. Kostenko, N. N. Кorotkikh, I. V. Zarodnyuk, J. L. Trubacheva, V. V. Veselov, A. A. Likutov, V. N. Kashnikov, S. A. Frolov, P. A. Yartsev, I. D. Loranskaya, B. A. Vykova, O. S. Shifrin, E. A. Poluektova, Z. A. Mamieva, A. I. Ulyanin, T. V. Shkurko. CLINICAL GUIDELINES Diverticular disease (57.2, 57.3), adults. Koloproktologia 2024; 23(2): 10 doi: 10.33878/2073-7556-2024-23-2-10-27
|
29 |
Angel Lanas, Daniel Abad-Baroja, Aitor Lanas-Gimeno. Progress and challenges in the management of diverticular disease: which treatment?. Therapeutic Advances in Gastroenterology 2018; 11: 175628481878905 doi: 10.1177/1756284818789055
|
30 |
G. Latella. Diverticular Disease: Emerging Evidence in a Common Condition. Falk Symposium 2006; 148: 161 doi: 10.1007/1-4020-4318-X_20
|
31 |
Hendrike E. Bolkenstein, Esther C. J. Consten, Job van der Palen, Bryan J. M. van de Wall, Ivo A. M. J. Broeders, Willem A. Bemelman, Johan F. Lange, Marja A. Boermeester, Werner A. Draaisma. Long-term Outcome of Surgery Versus Conservative Management for Recurrent and Ongoing Complaints After an Episode of Diverticulitis. Annals of Surgery 2019; 269(4): 612 doi: 10.1097/SLA.0000000000003033
|
32 |
Brennan Spiegel. Gravity and the Gut: A Hypothesis of Irritable Bowel Syndrome. American Journal of Gastroenterology 2022; 117(12): 1933 doi: 10.14309/ajg.0000000000002066
|
33 |
Antonio Tursi. Balsalazide Plus High-potency Probiotic Preparation (VSL♯3) in the Treatment of Acute Mild-to-moderate Ulcerative Colitis and Uncomplicated Diverticulitis of the Colon. Journal of Clinical Gastroenterology 2008; 42(Supplement 3): S119 doi: 10.1097/MCG.0b013e31815f5ac7
|
34 |
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
Abstract(543) |
Core Tip(464) |
Full Article(HTML)(2932)
|
Full Article with Cover (PDF)-2077K(78)
|
Full Article (Word)-351K(55)
|
Audio-395K(8)
|
Peer-Review Report-291K(52)
|
Answering Reviewers-97K(58)
|
Full Article (PDF)-967K(273)
|
Full Article (XML)-396K(62)
|
Times Cited (9)
|
Total Visits (6241)
|
Open
|
35 |
Rocco Ricciardi, Susannah Clark, Patricia L. Roberts. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; : 1826 doi: 10.1016/B978-0-323-40232-3.00157-6
|
36 |
Antonio Tursi, Giovanni Brandimarte, Gian Marco Giorgetti, Walter Elisei. Transient Lactose Malabsorption in Patients Affected by Symptomatic Uncomplicated Diverticular Disease of the Colon. Digestive Diseases and Sciences 2006; 51(3): 461 doi: 10.1007/s10620-006-3155-6
|
37 |
Angèle P. M. Kerckhoffs, Maarten R. Visser, Melvin Samsom, Michel E. van der Rest, Joris de Vogel, Wil Harmsen, Louis M. A. Akkermans. Critical Evaluation of Diagnosing Bacterial Overgrowth in the Proximal Small Intestine. Journal of Clinical Gastroenterology 2008; 42(10): 1095 doi: 10.1097/MCG.0b013e31818474d7
|
38 |
Doron Boltin, Tsachi Tsadok Perets, Einav Shporn, Shoshana Aizic, Sigal Levy, Yaron Niv, Ram Dickman. Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome. Annals of Clinical Microbiology and Antimicrobials 2014; 13(1) doi: 10.1186/s12941-014-0049-x
|
39 |
Bryan J M van de Wall, Marguerite A W Stam, Werner A Draaisma, R Stellato, Willem A Bemelman, Marja A Boermeester, Ivo A M J Broeders, Eric J Belgers, Boudewijn R Toorenvliet, Hubert A Prins, Esther C J Consten. Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology & Hepatology 2017; 2(1): 13 doi: 10.1016/S2468-1253(16)30109-1
|
40 |
Antonio Tursi, Raymond E. Joseph, Paul Streck. Expanding Applications: The Potential Usage of 5-Aminosalicylic Acid in Diverticular Disease. Digestive Diseases and Sciences 2011; 56(11): 3112 doi: 10.1007/s10620-011-1731-x
|
41 |
Sanjoy Ghosh, Erin Molcan, Daniella DeCoffe, Chaunbin Dai, Deanna L. Gibson. Diets rich inn-6 PUFA induce intestinal microbial dysbiosis in aged mice. British Journal of Nutrition 2013; 110(3): 515 doi: 10.1017/S0007114512005326
|
42 |
Antonio Tursi. Diverticulosis today: unfashionable and still under-researched. Therapeutic Advances in Gastroenterology 2016; 9(2): 213 doi: 10.1177/1756283X15621228
|
43 |
Brennan M. R. Spiegel, Mark W. Reid, Roger Bolus, Cynthia B. Whitman, Jennifer Talley, Stanley Dea, Kamyar Shahedi, Hetal Karsan, Chassidy Teal, Gil Y. Melmed, Erica Cohen, Garth Fuller, Linnette Yen, Paul Hodgkins, M. Haim Erder. Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL. Quality of Life Research 2015; 24(1): 163 doi: 10.1007/s11136-014-0753-1
|